Last Updated: October 25, 2026
A cream can contain an interesting anti-inflammatory ingredient without being shown to prevent an acne scar. That distinction matters when “calming” skincare starts being marketed as a treatment for breakouts, dark marks and permanent texture changes at once.
Medical disclaimer: This article is educational, not a diagnosis or treatment plan. Seek qualified care for persistent acne, painful nodules, scarring or significant distress. Do not stop prescribed treatment or apply a cosmetic to an open lesion or procedural site based on this article.
Start by separating three different goals
Active acne, post-acne pigmentation and structural scarring are not interchangeable study endpoints. Anwar et al. (2021), Skinmed, studied pigmentation measurements in a combination-serum trial, not acne clearance or prevention of indented scars. Reynolds et al. (2024), Journal of the American Academy of Dermatology, address treatment selection and escalation for acne, including disease associated with scarring. PMID: 33938432; PMID: 38300170.
Before buying another cica product, decide which problem you are evaluating. “My skin feels more comfortable” is a useful personal observation, but it does not establish fewer new lesions, lighter pigmentation or scar remodeling.
Centella mechanisms: a rationale, not an acne response rate
Tier 3, predominantly mechanistic rationale: Park (2021), Evidence-Based Complementary and Alternative Medicine, reviewed centella and its triterpenes, including madecassoside, asiaticoside, asiatic acid and madecassic acid. The review discusses laboratory and in-vivo findings involving inflammatory and repair-related pathways. It also calls for additional rigorously controlled long-term clinical trials. PMID: 34845411.
Those findings help explain why centella is investigated. They do not establish a clinical percentage reduction in acne lesions from any retail ampoule, or prove that a cream prevents post-acne pigmentation or scars. Research on cell signaling should not be promoted to Tier 1 acne efficacy simply because several mechanisms sound relevant. Park (2021), Evidence-Based Complementary and Alternative Medicine, PMID: 34845411.
Here, Tier 1 means multiple randomized human trials for a defined outcome; Tier 2 means limited human clinical evidence; Tier 3 means primarily mechanistic evidence; Tier 4 means the proposed clinical claim remains unconfirmed in the evidence reviewed. A botanical's tier changes with the claim being assessed.
The human pigmentation trial: promising, but a combination
Tier 2, one randomized combination-serum trial: Anwar et al. (2021), Skinmed, studied 51 participants with post-acne hyperpigmentation and Fitzpatrick skin types IV or V. Participants received either a serum containing galactomyces ferment filtrate, dexpanthenol and centella or placebo, used twice daily for eight weeks. Outcomes included melanin index and a lightness score. PMID: 33938432.
Findings differed by skin-type subgroup and time point: lightness scores favored treatment in skin type V at weeks four and six, while melanin index favored treatment in skin type IV after eight weeks. These are narrower findings than “centella clears all acne marks.” They do not isolate centella from the other ingredients or establish the same result in a different cream. Anwar et al. (2021), Skinmed, PMID: 33938432.
Tier 4 for a centella-alone scar-prevention claim: This trial did not establish prevention of structural acne scars, faster healing of active pimples or independent efficacy of centella alone. It measured pigmentation, not those outcomes. Collagen-related mechanisms cannot fill that gap. Anwar et al. (2021), Skinmed, PMID: 33938432; Park (2021), Evidence-Based Complementary and Alternative Medicine, PMID: 34845411.
What evidence-supported acne care looks like
Tier 1 for established acne options, summarized in clinical guidance: Reynolds et al. (2024), Journal of the American Academy of Dermatology, strongly recommend benzoyl peroxide and topical retinoids based on their evidence reviews. The guideline also discusses other topical and systemic options and strongly recommends isotretinoin for appropriate severe, scarring, burdensome or treatment-resistant disease. These are clinician-guided choices, not a recommendation that every reader use the same medicines. PMID: 38300170.
The point is not that all botanicals are useless. It is that a centella cosmetic should not inherit the clinical evidence of an acne medicine or delay reassessment when acne is scarring. Our acne care guide provides related reading; individual suitability still requires assessment.
A practical protocol: keep treatment, comfort and tracking separate
- Identify the target. Record whether you are trying to reduce new lesions, manage discomfort or assess leftover pigmentation. Avoid describing all three as “healing.”
- Keep your treatment plan explicit. Ask which acne medicines to continue and when to review progress. Do not replace them with a centella-only shopping routine.
- Make optional cosmetics genuinely optional. If you want to consider COSRX Centella Blemish Cream, review the full label and suitability. The catalog describes centella water and zinc oxide in a topical cream; it does not establish the centelloid dose or equivalence to the Anwar combination serum.
- Change one optional product at a time. As a practical tracking choice, this makes it easier to identify which new product coincided with discomfort or a perceived benefit. It is not a clinical guarantee of tolerance.
- Do not assume a universal application order. “Centella after benzoyl peroxide” or “before every retinoid” is not validated for every formula by the studies cited here. Follow the specific treatment instructions and ask about compatibility rather than adding an automatic buffer layer.
- Escalate scarring or persistent disease. Do not wait for a cosmetic collagen claim to solve structural changes. Reynolds et al. (2024), Journal of the American Academy of Dermatology, identify scarring and treatment failure as reasons for considering more intensive care. PMID: 38300170.
For the wider ingredient context, read our botanical-actives evidence guide. Our post-acne marks and scars guide provides related background; a cosmetic product listing is not evidence that it treats either concern.
What a product name cannot establish
Tier 4 for finished-product efficacy transfer: “Blemish cream,” “cica,” “poremizing” and “tested for irritation” do not establish acne clearance, non-comedogenicity for every user, scar prevention or universal compatibility. The cited pigmentation trial tested a particular combination serum, not the COSRX cream or the earlier article's multi-step cleanser-ampoule-pad-gel stack. Anwar et al. (2021), Skinmed, PMID: 33938432.
Likewise, the presence of zinc oxide in a cosmetic should not be treated as a verified sunscreen rating. No SPF claim for this cream is established in this review. Do not use an ingredient-based inference to replace a product labeled and intended as sunscreen.
Commercial disclosure: Veracil sells the cream below. It is optional cosmetic shopping context, not a product shown by the cited studies to clear acne, prevent scars or reproduce the combination-serum pigmentation findings.
Honest limitations
The evidence reviewed does not establish how much a centella-only product reduces new acne lesions, how quickly it clears a pimple, or whether it prevents permanent scars. The pigmentation trial was small, studied a combination and reported subgroup- and time-specific findings. Its population and formula limit generalization. Anwar et al. (2021), Skinmed, PMID: 33938432.
The calibrated verdict
Preliminary Confirm for the studied combination, not centella alone: One randomized serum study offers an early signal for post-acne pigmentation in defined skin-type subgroups. It does not validate every cica cream. Anwar et al. (2021), Skinmed, PMID: 33938432.
Inconclusive: A centella-only acne protocol, universal treatment-buffering benefit or prevention of acne scars by the retail cream linked here. The mechanistic review and combination study do not establish those outcomes. Park (2021), Evidence-Based Complementary and Alternative Medicine, PMID: 34845411; Anwar et al. (2021), Skinmed, PMID: 33938432.
Use centella as an optional cosmetic decision, not as a shortcut around evidence-supported acne care or timely scar assessment.
The Veracil Research Team
0 comments